In adaptive immunity, APS enhance the function of cytotoxic CD8+ T lymphocytes and reduce the population of immunosuppressive regulatory T cells (Tregs), thereby reversing tumour-induced immune tolerance [36]. This evidence concerns the gene CD8A and neoplasm.